Insider · CIK 0001955281
Joseph A. Tyndall
Files at AXGN (Axogen, Inc.). First filing May 23, 2025, latest Sep 4, 2026.
In brief
Joseph A. Tyndall files SEC Form 4 as director at AXGN (Axogen, Inc.). Since May 23, 2025, Joseph A. Tyndall has reported 0 open-market buys worth $0 and 5 open-market sells worth $1.5M, the latest filed on Sep 4, 2026.
A track record needs three past buys with six months of prices behind them; Joseph A. Tyndall has 0, so none is measured yet.
The newest scored trade: sold $174k of AXGN on Sep 2, 2026, filed Sep 4, 2026, scored 11 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $952k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXGN: Axogen, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | Axogen, Inc. | $174k 3,500 shares | -25% | - | |
| 57Moderate | Axogen, Inc. | $778k 25,108 shares | -100% | +229% from low-8% from high | |
| 49Moderate | Axogen, Inc. | $289k 26,931 shares | -100% | +3% from low-47% from high | |
| 25Weak | AXGNsell Axogen, Inc. | $29k 2,525 shares | -10% | +8% from low-42% from high | |
| 32Weak | AXGNsell Axogen, Inc. | $225k 20,062 shares | -57% | +1% from low-46% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 2, 2026 | AXGN Axogen, Inc. | 3,500 0.01% of outstanding | $175k | Sep 2, 2026 | none |
| Dec 9, 2025 | AXGN AXOGEN, INC. | 25,108 0.05% of outstanding | $778k | Dec 9, 2025 | none |
| Jun 10, 2025 | AXGN AXOGEN INC. | 26,931 0.06% of outstanding | $289k | Jun 10, 2025 | $254k |
| May 22, 2025 | AXGN Axogen, Inc. | 32,339 0.07% of outstanding | $361k | May 22, 2025 | $29k |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | AXGN Axogen, Inc. | SOpen-market sale Common Stock10b5-1 | -3,500 | $49.70 | $174k | 10,650 | 39 d ago |
| Jun 24, 2026 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,392 | $0.00 | $0 | 4,392 | Jun 26, 2026 |
| Jun 19, 2026 | AXGN Axogen, Inc. | MOption exercise Common Stock | +14,150 | $0.00 | $0 | 14,150 | Jun 23, 2026 |
| Jun 19, 2026 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | +14,150 | $0.00 | $0 | 0 | Jun 23, 2026 |
| Dec 9, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +14,248 | $7.04 | $100k | 14,248 | Dec 10, 2025 |
| Dec 9, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +10,860 | $10.95 | $119k | 25,108 | Dec 10, 2025 |
| Dec 9, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -14,248 | $30.98 | $441k | 10,860 | Dec 10, 2025 |
| Dec 9, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -10,860 | $30.98 | $336k | 0 | Dec 10, 2025 |
| Dec 9, 2025 | AXGN Axogen, Inc. | MOption exercise Employee Stock Option (right to purchase)derivative | -14,248 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 9, 2025 | AXGN Axogen, Inc. | MOption exercise Stock Option (right to purchase)derivative | -10,860 | $0.00 | $0 | 32,311 | Dec 10, 2025 |
| Jun 19, 2025 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +14,150 | $0.00 | $0 | 14,150 | Jun 20, 2025 |
| Jun 10, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +7,586 | $6.30 | $48k | 22,931 | Jun 11, 2025 |
| Jun 10, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +4,000 | $7.04 | $28k | 26,931 | Jun 11, 2025 |
| Jun 10, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -26,931 | $10.72 | $289k | 0 | Jun 11, 2025 |
| Jun 10, 2025 | AXGN Axogen, Inc. | MOption exercise Stock Option (right to purchase)derivative | -7,586 | $6.30 | $48k | 0 | Jun 11, 2025 |
| Jun 10, 2025 | AXGN Axogen, Inc. | MOption exercise Employee Stock Option (right to purchase)derivative | -4,000 | $7.04 | $28k | 14,248 | Jun 11, 2025 |
| May 22, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +12,850 | $6.30 | $81k | 35,407 | May 23, 2025 |
| May 19, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -2,525 | $11.63 | $29k | 22,557 | May 23, 2025 |
| May 22, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -12,850 | $11.20 | $144k | 22,557 | May 23, 2025 |
| May 22, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -7,212 | $11.20 | $81k | 15,345 | May 23, 2025 |
| May 22, 2025 | AXGN Axogen, Inc. | MOption exercise Stock Option (right to purchase)derivative | -12,850 | $6.30 | $81k | 7,586 | May 23, 2025 |
Questions about Joseph A. Tyndall
Answered from the filings on this page, as of the latest one.
Is Joseph A. Tyndall buying or selling?
In the last 12 months Joseph A. Tyndall reported 0 open-market buys worth $0 and 2 open-market sells worth $952k on SEC Form 4; the latest was sold $174k of AXGN on Sep 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Joseph A. Tyndall's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph A. Tyndall has 0.
Where does Joseph A. Tyndall file Form 4?
Joseph A. Tyndall has filed Form 4 at AXGN (Axogen, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.